| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 120.8 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 120.8. The average price that BIM.PA shares were previous bought at was EUR 110.633. The current market price is 9.2% higher than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 3,297 compared to the previous valuation of BioMerieux however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 298.142 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 298.142. The average price that RO.SW shares were previous bought at was CHF 302.302. The current market price is -1.4% lower than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 93,912 compared to the previous valuation of |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 49.49 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 49.49. The average price that FME.DE shares were previous bought at was EUR 46.8565. The current market price is 5.6% higher than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 34,002 compared to the previous valuation of Fresenius Medical Care AG |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 61.24 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 61.24. The average price that ERF.PA shares were previous bought at was EUR 51.0554. The current market price is 19.9% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 43,160 compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 214 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 214. The average price that SRT3.DE shares were previous bought at was EUR 220.626. The current market price is -3.0% lower than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 86,974 compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 26.3309 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 26.3309. The average price that SOBI.ST shares were previous bought at was SEK 26.9812. The current market price is -2.4% lower than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 27,017 compared to the previous valuation of however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 117.363 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 117.363. The average price that GALD.SW shares were previous bought at was CHF 104.269. The current market price is 12.6% higher than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 64,901 compared to the previous valuation of |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 204.4 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 204.4. The average price that DIM.PA shares were previous bought at was EUR 190.197. The current market price is 7.5% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 61,690 compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 54.7 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 54.7. The average price that REC.MI shares were previous bought at was EUR 52.548. The current market price is 4.1% higher than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 15,859 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 63.25 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 63.25. The average price that ORNBV.HE shares were previous bought at was EUR 50.7131. The current market price is 24.7% higher than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 2,145 compared to the previous valuation of Orion Oyj |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 12.6969 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 12.6969. The average price that SN.L shares were previous bought at was GBP 12.775. The current market price is -0.6% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 56,014 compared to the previous valuation of Smith & Nephew PLC |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 103.8 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 103.8. The average price that IPN.PA shares were previous bought at was EUR 107.092. The current market price is -3.1% lower than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 7,419 compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 24.6079 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 24.6079. The average price that HIK.L shares were previous bought at was GBP 24.4976. The current market price is 0.5% higher than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 27,955 compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 37.4086 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 37.4086. The average price that DEMANT.CO shares were previous bought at was DKK 34.1992. The current market price is 9.4% higher than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 11,798 compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.63 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.63. The average price that GRF.MC shares were previous bought at was EUR 10.2434. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 51,403 compared to the previous valuation of Grifols SA however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 93.98 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 93.98. The average price that DIA.MI shares were previous bought at was EUR 68.5775. The current market price is 37.0% higher than average price they were purchased at. The value of the holding in DIA.MI has increased by EUR 5,927 compared to the previous valuation of DiaSorin SpA however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 66.7858 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 66.7858. The average price that NOVO-B.CO shares were previous bought at was DKK 65.9517. The current market price is 1.3% higher than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 3,095,636 compared to the previous valuation of Novo Nordisk A/S |
| COLO-B.CO - | HOLD | 0 @ DKK 85.1951 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 85.1951. The average price that COLO-B.CO shares were previous bought at was DKK 92.5737. The current market price is -8.0% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 10,681 compared to the previous valuation of |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 40.805 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 40.805. The average price that QIA.DE shares were previous bought at was EUR 37.624. The current market price is 8.5% higher than average price they were purchased at. The value of the holding in QIA.DE has increased by EUR 10,685 compared to the previous valuation of QIAGEN NV however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.58612 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.58612. The average price that HLN.L shares were previous bought at was GBP 4.70903. The current market price is -2.6% lower than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 259,130 compared to the previous valuation of Haleon PLC |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 27.575 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 27.575. The average price that BAYN.DE shares were previous bought at was EUR 21.9962. The current market price is 25.4% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 36,976 compared to the previous valuation of Bayer AG however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 102.541 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 102.541. The average price that NOVN.SW shares were previous bought at was CHF 98.158. The current market price is 4.5% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 839,923 compared to the previous valuation of |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 126.887 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 126.887. The average price that AZN.L shares were previous bought at was GBP 128.315. The current market price is -1.1% lower than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 1,426,197 compared to the previous valuation of AstraZeneca PLC |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 85.88 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 85.88. The average price that SAN.PA shares were previous bought at was EUR 95.2663. The current market price is -9.9% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 404,655 compared to the previous valuation of Sanofi SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 17.4237 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 17.4237. The average price that GSK.L shares were previous bought at was GBP 16.7885. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 576,091 compared to the previous valuation of GlaxoSmithKline PLC |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 242.8 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 242.8. The average price that EL.PA shares were previous bought at was EUR 248.822. The current market price is -2.4% lower than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 94,257 compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 603.306 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 603.306. The average price that LONN.SW shares were previous bought at was CHF 584.866. The current market price is 3.2% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 100,782 compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 74.2694 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 74.2694. The average price that ALC.SW shares were previous bought at was CHF 81.3862. The current market price is -8.7% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 271,375 compared to the previous valuation of |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 483.1 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 483.1. The average price that ARGX.BR shares were previous bought at was EUR 551.897. The current market price is -12.5% lower than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 471,822 compared to the previous valuation of Argenx SE |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 161.95 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 161.95. The average price that UCB.BR shares were previous bought at was EUR 171.449. The current market price is -5.5% lower than average price they were purchased at. The value of the holding in UCB.BR has fallen by EUR 75,137 compared to the previous valuation of UCB SA |
| ROG.SW - | HOLD | 0 @ CHF 279.734 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 279.734. The average price that ROG.SW shares were previous bought at was CHF 285.605. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 2,226,064 compared to the previous valuation of |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 19.8 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 19.8. The average price that PHIA.AS shares were previous bought at was EUR 22.709. The current market price is -12.8% lower than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 27,946 compared to the previous valuation of Koninklijke Philips NV |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 114.65 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 114.65. The average price that MRK.DE shares were previous bought at was EUR 130.164. The current market price is -11.9% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 7,680 compared to the previous valuation of Merck KGaA |
| SDZ.SW - | HOLD | 0 @ CHF 45.2214 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 45.2214. The average price that SDZ.SW shares were previous bought at was CHF 40.3939. The current market price is 12.0% higher than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 65,821 compared to the previous valuation of |
| SOON.SW - | HOLD | 0 @ CHF 266.008 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 266.008. The average price that SOON.SW shares were previous bought at was CHF 291.912. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 37,741 compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 46.04 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 46.04. The average price that SHL.DE shares were previous bought at was EUR 48.2129. The current market price is -4.5% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 52,289 compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 43.98 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 43.98. The average price that FRE.DE shares were previous bought at was EUR 37.9992. The current market price is 15.7% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 3,347 compared to the previous valuation of Fresenius SE & Co KGaA |
| GMAB.CO - | HOLD | 0 @ DKK 197.702 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 197.702. The average price that GMAB.CO shares were previous bought at was DKK 190.425. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 22,085 compared to the previous valuation of |
| STMN.SW - | HOLD | 0 @ CHF 112.362 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 112.362. The average price that STMN.SW shares were previous bought at was CHF 118.249. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 17,471 compared to the previous valuation of however if the holding was sold on 2025-06-16 this would crystalise an overall loss. |